October 1, 2008 — GE Healthcare and Gamma Medica-Ideas (GM-I) have extended their product distribution relationship to include joint development of pre-clinical imaging systems.
Under the new agreement, which takes effect today. GM-I will manufacture all pre-clinical PET, SPECT and CT products sold by GE Healthcare, including the new eXplore CT120 and SpeCZT model lines. The companies will jointly pursue new pre-clinical product developments expected to lead to exciting new products for pre-clinical imaging. GE Healthcare will continue promotion, marketing, sales, and service responsibilities.
“GM-I has a long track record of innovation in imaging technologies and the pre-clinical business including the introduction of the first APD based PET scanner and the Triumph tri-modality system,” said Jim Mitchell, general manager of the pre-clinical business for GE Healthcare. “This agreement is tremendously beneficial to both companies, bringing GM-I’s engineering and manufacturing expertise and GE’s sales, marketing and services acumen together as well as combining cutting edge pre-clinical imaging technologies of GE and GMI.”
“This is a great opportunity to harmonize GM-I and GE Healthcare’s unique and innovative CZT SPECT, APD PET and high throughput CT imaging systems,” said Bradley Patt Ph.D., CEO of GM-I.
For more information: www.gehealthcare.com and www.gm-ideas.com
October 19, 2026 
